Alvogen Group

Alvotech is a fully integrated biopharmaceutical company dedicated to the development and manufacture of high-quality biosimilar medicines. Founded in 2013 by Róbert Wessman in Reykjavík, the company aims to enhance patients' health and quality of life worldwide by increasing access to effective therapies for various ailments. Through its focus on biosimilars, Alvotech strives to provide proven treatments that address the needs of patients globally.

Kerecis is a company that develops patented fish-skin products aimed at healing human wounds and repairing tissue damage. Utilizing fish skin, which poses no disease-transfer risk to humans, Kerecis produces therapeutic products that retain similarities to human skin, making them effective substitutes. The company's offerings are enriched with Omega-3 fatty acids extracted from fish skin, which aid in the reconstruction of various types of tissue damage, including burns, diabetic wounds, and surgical repairs such as hernias and breast reconstruction. Kerecis's technology is supported by over 50 studies, including double-blind, randomized control trials demonstrating the efficacy of fish skin treatments compared to traditional mammalian-based solutions. In addition to wound care, Kerecis is expanding its product line to include applications in oral surgery, plastic surgery, and neurology, highlighting its commitment to advancing tissue regeneration and healing methods.

Bittner Pharma is a pharmaceutical company based in Moscow, Russia, founded in 1987. It specializes in the distribution and manufacturing of pharmaceuticals, particularly focusing on a targeted portfolio of over-the-counter drugs. Its product range includes homeopathic medicinal products for various health concerns, such as cold and flu remedies, as well as treatments for heart problems. Operating as a subsidiary of Perrigo Company plc, Bittner Pharma aims to address specific healthcare needs, particularly in women's health and respiratory issues.

OOO Dolfin is a Moscow-based company specializing in the production of anti-inflammatory, immunomodulatory, and antiseptic agents designed to combat infections. The company focuses on developing innovative pharmaceutical solutions to address various health challenges. Since November 28, 2016, OOO Dolfin has operated as a subsidiary of Alvogen, Inc., which has allowed it to enhance its operational capabilities and expand its market presence.

County Line Pharmaceuticals, founded in 2007 by experienced pharmaceutical executives, specializes in the manufacturing of generic pharmaceutical products. The founding team, which previously held significant roles at Schwarz Pharma Inc. and contributed to the establishment of Kremers Urban, brings a wealth of industry knowledge to the company. County Line Pharmaceuticals offers a diverse range of products, including oral medicines, creams, ointments, gels, and orally disintegrating tablets, catering to various therapeutic needs within the healthcare sector.

Dream Pharma Corp., pharmaceutical company, manufactures prescription and OTC medications in South Korea. It offers tablets, capsules, creams, injections, and powders in the areas of antihistamines, pain, gastrointestinal, respiratory, circulatory, dermatology, anti-obesities, and others; and nutritional dietary supplements. The company exports its products to India and Vietnam; and offers its products through partnerships with pharmaceutical companies in the United States, Asia, and Europe. Dream Pharma Corp. was formerly known as H-Pharm Co., Ltd. and changed its name to Dream Pharma Corp. in January 2005. The company was founded in 1995 and is based in Seoul, South Korea. Dream Pharma Corp. operates as a subsidiary of Hanwha Corp.

LaborMed's initial focus was on building its portfolio of cardiovascular and central nervous systems treatments.